Related references
Note: Only part of the references are listed.A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome
E. D. Jacobsen et al.
ANNALS OF ONCOLOGY (2011)
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry
M. Michallet et al.
LEUKEMIA (2010)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery
Anna Dodero et al.
BLOOD (2009)
Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
Peter Reimer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
L. Farina et al.
LEUKEMIA (2009)
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
S. Mercadal et al.
ANNALS OF ONCOLOGY (2008)
Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: The Stanford experience
Andy I. Chen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: An analysis from the lymphoma working party of the European group for blood and marrow transplantation
Anna Sureda et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: A study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Steven Le Gouill et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The adjusted International Prognostic Index and β-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma
Jose Rodriguez et al.
HAEMATOLOGICA (2007)
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation
P. Corradini et al.
LEUKEMIA (2006)
Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan
Sung-Won Kim et al.
BLOOD (2006)
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis
P Dreger et al.
LEUKEMIA (2005)
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
P Corradini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling
JP Klein et al.
BONE MARROW TRANSPLANTATION (2001)
Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin
T Lamparelli et al.
BONE MARROW TRANSPLANTATION (2000)